p38-dependent marking of inflammatory genes for increased NF-κB recruitment
Top Cited Papers
- 17 December 2001
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 3 (1) , 69-75
- https://doi.org/10.1038/ni748
Abstract
We found that inflammatory stimuli induce p38 mitogen-activated protein kinase–dependent phosphorylation and phosphoacetylation of histone H3; this selectively occurred on the promoters of a subset of stimulus-induced cytokine and chemokine genes. p38 activity was required to enhance the accessibility of the cryptic NF-κB binding sites contained in H3 phosphorylated promoters, which indicated that p38-dependent H3 phosphorylation may mark promoters for increased NF-κB recruitment. These results show that p38 plays an additional role in the induction of the inflammatory and immune response: the regulation of NF-κB recruitment to selected chromatin targets.Keywords
This publication has 46 references indexed in Scilit:
- Two Waves of Nuclear Factor κb Recruitment to Target PromotersThe Journal of Experimental Medicine, 2001
- Signal Transduction by the JNK Group of MAP KinasesPublished by Elsevier ,2000
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- The language of covalent histone modificationsNature, 2000
- MAP kinase-mediated signalling to nucleosomes and immediate-early gene inductionSeminars in Cell & Developmental Biology, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Identification and Characterization of an IκB KinaseCell, 1997
- Origin, maturation and antigen presenting function of dendritic cellsCurrent Opinion in Immunology, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994